Literature DB >> 30353821

Treatment of Comorbid Obstructive Sleep Apnea by Upper Airway Stimulation Results in Resolution of Debilitating Symptoms of Restless Legs Syndrome.

Lukasz A Myc1, Ian T Churnin2, Mark J Jameson2, Eric M Davis1.   

Abstract

ABSTRACT: An association between restless legs syndrome (RLS) and obstructive sleep apnea (OSA) has been suggested for decades but has been questioned in recent years given the apparently similar prevalence of RLS among patients with OSA and the general population. Still, marked improvement in symptoms of RLS has been reported in patients with OSA treated with continuous positive airway pressure (CPAP). Whether the effect of OSA treatment on RLS extends to modalities of OSA treatment other than CPAP remains an open question. Here, we report the case of a patient with OSA and comorbid debilitating RLS who underwent upper airway stimulation device implantation and subsequently experienced near-resolution of her severe RLS symptoms. Upper airway stimulation devices may be an option for patients with OSA and severe RLS intolerant to conventional CPAP modalities.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  obstructive sleep apnea; restless legs syndrome; upper airway stimulator

Mesh:

Year:  2018        PMID: 30353821      PMCID: PMC6175797          DOI: 10.5664/jcsm.7400

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  10 in total

1.  Clinically significant but unsuspected restless legs syndrome in patients with sleep apnea.

Authors:  Sowmya Lakshminarayanan; Kanchana Devi Paramasivan; Arthur S Walters; Mary L Wagner; Shivani Patel; Vandna Passi
Journal:  Mov Disord       Date:  2005-04       Impact factor: 10.338

2.  Upper-airway stimulation for obstructive sleep apnea.

Authors:  Patrick J Strollo; Ryan J Soose; Joachim T Maurer; Nico de Vries; Jason Cornelius; Oleg Froymovich; Ronald D Hanson; Tapan A Padhya; David L Steward; M Boyd Gillespie; B Tucker Woodson; Paul H Van de Heyning; Mark G Goetting; Oliver M Vanderveken; Neil Feldman; Lennart Knaack; Kingman P Strohl
Journal:  N Engl J Med       Date:  2014-01-09       Impact factor: 91.245

3.  Hypoxia-inducible factor pathway activation in restless legs syndrome patients.

Authors:  S M Patton; P Ponnuru; A M Snyder; G D Podskalny; J R Connor
Journal:  Eur J Neurol       Date:  2011-04-05       Impact factor: 6.089

4.  Outcome of restless legs severity after continuous positive air pressure (CPAP) treatment in patients affected by the association of RLS and obstructive sleep apneas.

Authors:  Raimundo Nonato Delgado Rodrigues; Aída Alexandra Alvim de Abreu E Silva Rodrigues; Riccardo Pratesi; Jean Krieger
Journal:  Sleep Med       Date:  2006-03-24       Impact factor: 3.492

5.  The urge to move and breathe - the impact of obstructive sleep apnea syndrome treatment in patients with previously diagnosed, clinically significant restless legs syndrome.

Authors:  Cristiana Silva; Ana Rita Peralta; Carla Bentes
Journal:  Sleep Med       Date:  2017-07-22       Impact factor: 3.492

6.  The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.

Authors:  Diego Garcia-Borreguero; Ralf Kohnen; Michael H Silber; John W Winkelman; Christopher J Earley; Birgit Högl; Mauro Manconi; Jacques Montplaisir; Yuichi Inoue; Richard P Allen
Journal:  Sleep Med       Date:  2013-07       Impact factor: 3.492

7.  Assessing health-related quality of life in patients with restless legs syndrome.

Authors:  Svenja Happe; Jens Peter Reese; Karin Stiasny-Kolster; Ines Peglau; Geert Mayer; Jens Klotsche; Guido Giani; Max Geraedts; Claudia Trenkwalder; Richard Dodel
Journal:  Sleep Med       Date:  2008-03-24       Impact factor: 3.492

Review 8.  Differential Diagnoses of Restless Legs Syndrome/Willis-Ekbom Disease: Mimics and Comorbidities.

Authors:  Sudhansu Chokroverty
Journal:  Sleep Med Clin       Date:  2015-09

9.  Upper Airway Stimulation for Obstructive Sleep Apnea: 5-Year Outcomes.

Authors:  B Tucker Woodson; Kingman P Strohl; Ryan J Soose; M Boyd Gillespie; Joachim T Maurer; Nico de Vries; Tapan A Padhya; M Safwan Badr; Ho-Sheng Lin; Olivier M Vanderveken; Sam Mickelson; Patrick J Strollo
Journal:  Otolaryngol Head Neck Surg       Date:  2018-03-27       Impact factor: 3.497

10.  Restless legs syndrome in patients with chronic obstructive pulmonary disease.

Authors:  Yuksel Kaplan; Handan Inonu; Ayse Yilmaz; Serpil Ocal
Journal:  Can J Neurol Sci       Date:  2008-07       Impact factor: 2.104

  10 in total
  3 in total

1.  Hypoglossal Nerve Stimulation Therapy.

Authors:  Philipp Arens; Toni Hänsel; Yan Wang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Impact of Positive Airway Pressure on International Restless Legs Syndrome Score in Sleep Disordered Breathing.

Authors:  Seetha Lakshmanan; Nicolas R Thompson; Maeve Pascoe; Reena Mehra; Nancy Foldvary-Schaefer; Irene L Katzan; Harneet K Walia
Journal:  J Clin Med       Date:  2019-12-14       Impact factor: 4.241

3.  Clinical and polysomnographic characteristics in adults referred to the sleep laboratory: a single-center study.

Authors:  Samrad Mehrabi; Soroush Bagheri
Journal:  Qatar Med J       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.